CYCLOPHARM LIMITED
ASX:CYCHealth Care Equipment & ServicesRunway under 2 quarters; share count grew 14% in 24 months; 1 cash raise in 24 months
CYCLOPHARM LIMITED held 126M ordinary shares as of July 2026. Its share-count growth over the period is not stated, as the filed Appendix 2A series ends earlier than that date. The company completed one capital raise in the past 24 months, a Placement and Security Purchase Plan in February 2026 raising A$14.2M. No options or rights are disclosed on issue from Appendix 2 filings. No proposed securities issues are currently pending. The company has under 2 quarters of funding at the recent spend rate, based on its latest half-year or annual report rather than a quarterly cash report.
Quick answers · 2
When did CYC last raise capital?
The last capital raise in Cyclopharm's filings is Placement and Security Purchase Plan of $14.2M announced 4 Feb 2026, one of 1 cash raises in 24 months.
How much placement capacity does CYC have left?
About 12% of the 15% placement capacity left, about 88% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 6 July 2026 | 3H · cancellation | CYC : ORDINARY FULLY PAID | 125.7M | Appendix 3H |
| 20 Apr 2026 | 2A · quoted issue | CYC : ORDINARY FULLY PAID | 126.1M | Appendix 2A |
| 12 Mar 2026 | 2A · quoted issue | CYC : ORDINARY FULLY PAID | 120.8M | Appendix 2A |
| 11 Feb 2026 | 2A · quoted issue | CYC : ORDINARY FULLY PAID | 120.6M | Appendix 2A |
| 28 June 2024 | 2A · quoted issue | CYC : ORDINARY FULLY PAID | 111.1M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 12 Mar 2026 | David James Heaney | Buy entitlement/SPP | 21k | — | — | $20k | 3Y notice |
| 12 Mar 2026 | Dianne Margaret Angus | Buy entitlement/SPP | 21k | — | — | $20k | 3Y notice |
| 12 Mar 2026 | James McBrayer | Buy entitlement/SPP | 10 | — | — | $10k | 3Y notice |
| 12 Mar 2026 | John William Wigglesworth | Buy entitlement/SPP | 21k | — | — | $20k | 3Y notice |
| 12 Mar 2026 | Kevin Michael John Barrow | Buy entitlement/SPP | 5k | — | — | $5k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.